New Findings in Angioedema Described from Ogarev Mordovia State University (Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension).
In: Cardiovascular Week, 2023-10-09, S. 434-434
serialPeriodical
Zugriff:
According to news reporting originating from Ogarev Mordovia State University by NewsRx correspondents, research stated, "Angioneurotic edema is the most dangerous complication in angiotensin-converting enzyme inhibitors (ACEIs) therapy." The study enrolled 111 subjects randomized into two groups: study group, patients with the angioedema as a secondary side effect to enalapril; and control group, patients without adverse drug reaction. Keywords: ACE Inhibitors; Angioedema; Angioneurotic Edema; Angiotensin-Converting Enzyme Inhibitors; Antihypertensives; Biomarkers; Cardiovascular Agents; Cardiovascular Diseases and Conditions; Diagnostics and Screening; Dipeptides; Drugs and Therapies; Enalapril Therapy; Genetics; Health and Medicine; Hypersensitivity; Hypertension; Immune System Diseases and Conditions; Peptides; Pharmaceuticals; Pharmacogenetics; Skin Diseases and Conditions; Skin and Connective Tissue Diseases and Conditions; Urticaria; Vascular Skin Diseases and Conditions EN ACE Inhibitors Angioedema Angioneurotic Edema Angiotensin-Converting Enzyme Inhibitors Antihypertensives Biomarkers Cardiovascular Agents Cardiovascular Diseases and Conditions Diagnostics and Screening Dipeptides Drugs and Therapies Enalapril Therapy Genetics Health and Medicine Hypersensitivity Hypertension Immune System Diseases and Conditions Peptides Pharmaceuticals Pharmacogenetics Skin Diseases and Conditions Skin and Connective Tissue Diseases and Conditions Urticaria Vascular Skin Diseases and Conditions 434 434 1 10/09/23 20231009 NES 231009 2023 OCT 9 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Investigators publish new report on angioedema. [Extracted from the article]
Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Findings in Angioedema Described from Ogarev Mordovia State University (Pharmacogenetic markers of development of angioneurotic edema as a secondary side effect to enalapril in patients with essential arterial hypertension).
|
---|---|
Zeitschrift: | Cardiovascular Week, 2023-10-09, S. 434-434 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1543-6853 (print) |
Schlagwort: |
|
Sonstiges: |
|